{"transactions":[{"id":4631316,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T23:24:40.000Z","date":"2026-10-02","kind":"purchase","planned":false,"acquired":true,"shares":16575,"price":3.8758,"value":64241.385,"ownership":{"direct":false,"nature":"Holdings of BML Investment Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were purchased in multiple transactions at an average price of $3.8758 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2764610,"source":{"system":"sec-edgar","filing":"0001373604-26-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000137360426000050/form4.xml","form_type":"4"}},{"id":4631315,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T23:24:40.000Z","date":"2026-10-01","kind":"purchase","planned":false,"acquired":true,"shares":228334,"price":3.53,"value":806019.02,"ownership":{"direct":false,"nature":"Holdings of BML Investment Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions between $2.90 and $3.85 with an average price of $3.53."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2748035,"source":{"system":"sec-edgar","filing":"0001373604-26-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000137360426000050/form4.xml","form_type":"4"}},{"id":683443,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-08-18T23:45:51.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":3437,"price":4.39,"value":15088.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 9,319 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":194597,"source":{"system":"sec-edgar","filing":"0001484612-26-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000050/edgardoc.xml","form_type":"4"}},{"id":684462,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-18T22:51:48.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2632,"price":4.39,"value":11554.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":87475,"source":{"system":"sec-edgar","filing":"0001484612-26-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000048/edgardoc.xml","form_type":"4"}},{"id":683608,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22260,"kind":"person","name":"Gaeta Renee","position":1,"cik":"0001742428","reported_name":"Gaeta Renee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:46:00.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":4543,"price":4.39,"value":19943.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 12,322 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":180840,"source":{"system":"sec-edgar","filing":"0001484612-26-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742428/000148461226000047/edgardoc.xml","form_type":"4"}},{"id":724737,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-29T23:17:30.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":59830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":90107,"source":{"system":"sec-edgar","filing":"0001484612-26-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000045/edgardoc.xml","form_type":"4"}},{"id":724080,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22260,"kind":"person","name":"Gaeta Renee","position":1,"cik":"0001742428","reported_name":"Gaeta Renee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T23:15:34.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":71630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":185383,"source":{"system":"sec-edgar","filing":"0001484612-26-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742428/000148461226000043/edgardoc.xml","form_type":"4"}},{"id":723948,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-06-29T23:13:19.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":99160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":198034,"source":{"system":"sec-edgar","filing":"0001484612-26-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000041/edgardoc.xml","form_type":"4"}},{"id":747851,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:59:23.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":105839,"source":{"system":"sec-edgar","filing":"0001484612-26-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000039/edgardoc.xml","form_type":"4"}},{"id":747850,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:14:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":34785,"source":{"system":"sec-edgar","filing":"0001484612-26-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000035/edgardoc.xml","form_type":"4"}},{"id":747849,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:11:22.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":29334,"source":{"system":"sec-edgar","filing":"0001484612-26-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000034/edgardoc.xml","form_type":"4"}},{"id":747848,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40904,"kind":"person","name":"LANG BRENT D.","position":1,"cik":"0001544336","reported_name":"LANG BRENT D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:10:58.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":28518,"source":{"system":"sec-edgar","filing":"0001484612-26-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000033/edgardoc.xml","form_type":"4"}},{"id":747847,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":16987,"kind":"person","name":"GROSSMAN D KEITH","position":1,"cik":"0001218702","reported_name":"GROSSMAN D KEITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:08:47.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":24585,"source":{"system":"sec-edgar","filing":"0001484612-26-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000031/edgardoc.xml","form_type":"4"}},{"id":747846,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:08:38.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":21317,"source":{"system":"sec-edgar","filing":"0001484612-26-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000030/edgardoc.xml","form_type":"4"}},{"id":748047,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22260,"kind":"person","name":"Gaeta Renee","position":1,"cik":"0001742428","reported_name":"Gaeta Renee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T22:07:27.000Z","date":"2026-06-03","kind":"sale","planned":false,"acquired":false,"shares":17672,"price":4.94,"value":87299.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 32,856 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":113753,"source":{"system":"sec-edgar","filing":"0001484612-26-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742428/000148461226000029/edgardoc.xml","form_type":"4"}},{"id":771955,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-05-20T01:08:53.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":3445,"price":3.7,"value":12746.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 9,319 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 3,361 shares instead of the correct number, 3,384 shares."}],"balance_after":98874,"source":{"system":"sec-edgar","filing":"0001484612-26-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000027/edgardoc.xml","form_type":"4"}},{"id":771954,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2026-05-20T01:08:26.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":1582,"price":3.7,"value":5853.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,277 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 1,817 shares instead of the correct number, 1,830 shares."}],"balance_after":38393,"source":{"system":"sec-edgar","filing":"0001484612-26-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000026/edgardoc.xml","form_type":"4"}},{"id":773232,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-05-20T01:08:14.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":2638,"price":3.7,"value":9760.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 2,842 shares instead of the correct number, 2,862 shares."}],"balance_after":30277,"source":{"system":"sec-edgar","filing":"0001484612-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000025/edgardoc.xml","form_type":"4"}},{"id":774954,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-18T13:53:35.000Z","date":"2026-05-15","kind":"other","planned":false,"acquired":true,"shares":323000,"price":5,"value":1615000.0,"ownership":{"direct":false,"nature":"Holdings of BML Investment Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting owner was short June, 2026 put options and these shares were assigned on expiration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2519701,"source":{"system":"sec-edgar","filing":"0001373604-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000137360426000043/form4.xml","form_type":"4"}},{"id":782290,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-12T20:34:17.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":true,"shares":96900,"price":5,"value":484500.0,"ownership":{"direct":false,"nature":"Holdings of BML Investment Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2196701,"source":{"system":"sec-edgar","filing":"0001373604-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000137360426000036/form4.xml","form_type":"4"}},{"id":782289,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-12T20:34:17.000Z","date":"2026-05-08","kind":"other","planned":false,"acquired":true,"shares":197600,"price":5,"value":988000.0,"ownership":{"direct":false,"nature":"Holdings of BML Investment Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2099801,"source":{"system":"sec-edgar","filing":"0001373604-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000137360426000036/form4.xml","form_type":"4"}},{"id":812494,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":53246,"kind":"person","name":"Elliott Derick A.","position":1,"cik":"0002124076","reported_name":"Elliott Derick A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2026-04-08T21:21:00.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on April 6, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on April 6, 2027, and the remaining 66.66% shall vest in equal installments over the course of the following two years on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":96000,"source":{"system":"sec-edgar","filing":"0001484612-26-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000021/edgardoc.xml","form_type":"4"}},{"id":894486,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-02-20T01:57:47.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":2842,"price":3.35,"value":9520.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 5,032 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":32935,"source":{"system":"sec-edgar","filing":"0001823381-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000182338126000006/edgardoc.xml","form_type":"4"}},{"id":893284,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-02-20T01:57:07.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":3361,"price":3.35,"value":11259.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 9,319 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":102342,"source":{"system":"sec-edgar","filing":"0001304125-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000130412526000004/edgardoc.xml","form_type":"4"}},{"id":893283,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2026-02-20T01:56:10.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1817,"price":3.35,"value":6086.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,384 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":39988,"source":{"system":"sec-edgar","filing":"0001983815-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000198381526000004/edgardoc.xml","form_type":"4"}},{"id":934175,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2026-01-22T00:07:58.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":980,"price":4.98,"value":4880.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 14,839 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":41805,"source":{"system":"sec-edgar","filing":"0001484612-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000018/edgardoc.xml","form_type":"4"}},{"id":934174,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2026-01-22T00:07:58.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":5375,"price":5.12,"value":27520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 14,839 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":42785,"source":{"system":"sec-edgar","filing":"0001484612-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000018/edgardoc.xml","form_type":"4"}},{"id":934643,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-22T00:05:50.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":1180,"price":5.01,"value":5911.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":35777,"source":{"system":"sec-edgar","filing":"0001484612-26-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000017/edgardoc.xml","form_type":"4"}},{"id":934642,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-22T00:05:50.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":9314,"price":5.12,"value":47687.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":36957,"source":{"system":"sec-edgar","filing":"0001484612-26-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000017/edgardoc.xml","form_type":"4"}},{"id":934173,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-01-21T23:54:31.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":2120,"price":5.05,"value":10706.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 32,552 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":105703,"source":{"system":"sec-edgar","filing":"0001484612-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000015/edgardoc.xml","form_type":"4"}},{"id":934172,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-01-21T23:54:31.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":11794,"price":5.12,"value":60385.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 32,552 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":107823,"source":{"system":"sec-edgar","filing":"0001484612-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000015/edgardoc.xml","form_type":"4"}},{"id":940972,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":25394,"kind":"person","name":"Prange Karen","position":1,"cik":"0001566083","reported_name":"Prange Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T21:25:08.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":18667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted to the reporting person on January 9, 2026.  Each RSU represents a contingent right to receive one share of common stock.  These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":18667,"source":{"system":"sec-edgar","filing":"0001484612-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000007/edgardoc.xml","form_type":"4"}},{"id":943185,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2026-01-08T22:10:33.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":108,"price":4.27,"value":461.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 289 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":48160,"source":{"system":"sec-edgar","filing":"0001484612-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000006/edgardoc.xml","form_type":"4"}},{"id":943612,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-08T22:09:01.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":224,"price":4.27,"value":956.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 447 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46271,"source":{"system":"sec-edgar","filing":"0001484612-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461226000005/edgardoc.xml","form_type":"4"}},{"id":943184,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2026-01-08T22:05:21.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":1795,"price":4.27,"value":7664.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 4,904 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":119617,"source":{"system":"sec-edgar","filing":"0001484612-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000004/edgardoc.xml","form_type":"4"}},{"id":983512,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T22:39:04.000Z","date":"2025-12-01","kind":"sale","planned":false,"acquired":false,"shares":1548,"price":4.37,"value":6764.76,"ownership":{"direct":true},"balance_after":10650,"source":{"system":"sec-edgar","filing":"0001484612-25-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000081/edgardoc.xml","form_type":"4"}},{"id":995644,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-11-18T21:37:17.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":916,"price":4.6,"value":4213.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,770 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":121412,"source":{"system":"sec-edgar","filing":"0001484612-25-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000080/edgardoc.xml","form_type":"4"}},{"id":995645,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations R&D & Service"}}],"security":"Common Stock","published_at":"2025-11-18T21:33:55.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":247,"price":4.6,"value":1136.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 674 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":48268,"source":{"system":"sec-edgar","filing":"0001484612-25-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000079/edgardoc.xml","form_type":"4"}},{"id":996810,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-18T21:28:49.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":388,"price":4.6,"value":1784.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46495,"source":{"system":"sec-edgar","filing":"0001484612-25-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000078/edgardoc.xml","form_type":"4"}},{"id":1056793,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D, Operations and Serv."}}],"security":"Common Stock","published_at":"2025-08-25T23:59:58.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":5617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on August 25, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on August 15, 2026, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":48515,"source":{"system":"sec-edgar","filing":"0001484612-25-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000073/edgardoc.xml","form_type":"4"}},{"id":1063859,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-08-18T20:05:30.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":904,"price":12.88,"value":11643.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,769 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":122328,"source":{"system":"sec-edgar","filing":"0001484612-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000072/edgardoc.xml","form_type":"4"}},{"id":1063858,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-08-18T20:01:44.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":243,"price":12.88,"value":3129.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":42898,"source":{"system":"sec-edgar","filing":"0001484612-25-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000071/edgardoc.xml","form_type":"4"}},{"id":1064585,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T20:00:16.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":383,"price":12.88,"value":4933.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":46883,"source":{"system":"sec-edgar","filing":"0001484612-25-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000070/edgardoc.xml","form_type":"4"}},{"id":1114861,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-06-11T21:34:53.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":29676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":43141,"source":{"system":"sec-edgar","filing":"0001484612-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000062/edgardoc.xml","form_type":"4"}},{"id":1115630,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-06-11T21:33:48.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":35993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":47266,"source":{"system":"sec-edgar","filing":"0001484612-25-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000061/edgardoc.xml","form_type":"4"}},{"id":1114860,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-06-11T21:32:16.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":65103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on  February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":123232,"source":{"system":"sec-edgar","filing":"0001484612-25-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000060/edgardoc.xml","form_type":"4"}},{"id":1115050,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22260,"kind":"person","name":"Gaeta Renee","position":1,"cik":"0001742428","reported_name":"Gaeta Renee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T21:30:38.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":131425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted to the reporting person on June 10,2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 3, 2026, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":131425,"source":{"system":"sec-edgar","filing":"0001484612-25-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742428/000148461225000059/edgardoc.xml","form_type":"4"}},{"id":1122823,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":44886,"kind":"person","name":"Saia Andrea Lynn","position":1,"cik":"0001552993","reported_name":"Saia Andrea Lynn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:30:28.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":12175,"source":{"system":"sec-edgar","filing":"0001484612-25-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000058/edgardoc.xml","form_type":"4"}},{"id":1122824,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:29:29.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":24118,"source":{"system":"sec-edgar","filing":"0001484612-25-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000057/edgardoc.xml","form_type":"4"}},{"id":1122822,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40904,"kind":"person","name":"LANG BRENT D.","position":1,"cik":"0001544336","reported_name":"LANG BRENT D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:27:58.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":17851,"source":{"system":"sec-edgar","filing":"0001484612-25-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000056/edgardoc.xml","form_type":"4"}},{"id":1122821,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:26:53.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":95172,"source":{"system":"sec-edgar","filing":"0001484612-25-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000055/edgardoc.xml","form_type":"4"}},{"id":1122820,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":16987,"kind":"person","name":"GROSSMAN D KEITH","position":1,"cik":"0001218702","reported_name":"GROSSMAN D KEITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:23:40.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":13918,"source":{"system":"sec-edgar","filing":"0001484612-25-000054","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000054/edgardoc.xml","form_type":"4"}},{"id":1122819,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:22:25.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":12198,"source":{"system":"sec-edgar","filing":"0001484612-25-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000053/edgardoc.xml","form_type":"4"}},{"id":1145289,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-05-16T21:24:11.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":935,"price":17.8,"value":16643.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,770 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\").  Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":58129,"source":{"system":"sec-edgar","filing":"0001484612-25-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000048/edgardoc.xml","form_type":"4"}},{"id":1145288,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-05-16T21:22:58.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":252,"price":17.82,"value":4490.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\").  Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c)."}],"balance_after":13465,"source":{"system":"sec-edgar","filing":"0001484612-25-000047","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000047/edgardoc.xml","form_type":"4"}},{"id":1146218,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-16T21:21:39.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":396,"price":17.82,"value":7056.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":11273,"source":{"system":"sec-edgar","filing":"0001484612-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000046/edgardoc.xml","form_type":"4"}},{"id":1145287,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":79677,"kind":"person","name":"Ahmed Nabeel","position":1,"cik":"0001870610","reported_name":"Ahmed Nabeel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-16T21:20:28.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":584,"price":17.81,"value":10401.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the \"Reverse Stock Split\")."}],"balance_after":16096,"source":{"system":"sec-edgar","filing":"0001484612-25-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000045/edgardoc.xml","form_type":"4"}},{"id":1149146,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:06:40.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":15135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted to the reporting person on May 14, 2025.  Each RSU represents a contingent right to receive one share of common stock.  These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15135,"source":{"system":"sec-edgar","filing":"0001484612-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000040/edgardoc.xml","form_type":"4"}},{"id":1212101,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:32:39.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trigg 2002 Rev Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001484612-25-000038","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000038/edgardoc.xml","form_type":"4"}},{"id":1212100,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:32:39.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":200,"value":500000.0,"ownership":{"direct":false,"nature":"Trigg 2002 Rev Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":2500,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001484612-25-000038","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000038/edgardoc.xml","form_type":"4"}},{"id":1212099,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-03-11T20:32:39.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":625000,"ownership":{"direct":false,"nature":"Trigg 2002 Rev Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":625000,"source":{"system":"sec-edgar","filing":"0001484612-25-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000038/edgardoc.xml","form_type":"4"}},{"id":1212098,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40904,"kind":"person","name":"LANG BRENT D.","position":1,"cik":"0001544336","reported_name":"LANG BRENT D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:29:44.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Lang Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001484612-25-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000037/edgardoc.xml","form_type":"4"}},{"id":1212097,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40904,"kind":"person","name":"LANG BRENT D.","position":1,"cik":"0001544336","reported_name":"LANG BRENT D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:29:44.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":200,"value":200000.0,"ownership":{"direct":false,"nature":"Lang Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":1000,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001484612-25-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000037/edgardoc.xml","form_type":"4"}},{"id":1212096,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40904,"kind":"person","name":"LANG BRENT D.","position":1,"cik":"0001544336","reported_name":"LANG BRENT D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:29:44.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":false,"nature":"Lang Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001484612-25-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000037/edgardoc.xml","form_type":"4"}},{"id":1212095,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:25:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Drexler Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001484612-25-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000036/edgardoc.xml","form_type":"4"}},{"id":1212094,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:25:22.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":125,"price":200,"value":25000.0,"ownership":{"direct":false,"nature":"Drexler Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":125,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001484612-25-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000036/edgardoc.xml","form_type":"4"}},{"id":1212093,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":28204,"kind":"person","name":"Drexler Karen","position":1,"cik":"0001504699","reported_name":"Drexler Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:25:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":false,"nature":"Drexler Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001484612-25-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000036/edgardoc.xml","form_type":"4"}},{"id":1212092,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":16987,"kind":"person","name":"GROSSMAN D KEITH","position":1,"cik":"0001218702","reported_name":"GROSSMAN D KEITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:23:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Grossman Fam Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001484612-25-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000035/edgardoc.xml","form_type":"4"}},{"id":1212091,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":16987,"kind":"person","name":"GROSSMAN D KEITH","position":1,"cik":"0001218702","reported_name":"GROSSMAN D KEITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:23:58.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":750,"price":200,"value":150000.0,"ownership":{"direct":false,"nature":"Grossman Fam Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":750,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001484612-25-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000035/edgardoc.xml","form_type":"4"}},{"id":1212090,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":16987,"kind":"person","name":"GROSSMAN D KEITH","position":1,"cik":"0001218702","reported_name":"GROSSMAN D KEITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:23:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":187500,"ownership":{"direct":false,"nature":"Grossman Fam Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":192686,"source":{"system":"sec-edgar","filing":"0001484612-25-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000035/edgardoc.xml","form_type":"4"}},{"id":1212088,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Hackett Family Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212087,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":200,"value":500000.0,"ownership":{"direct":false,"nature":"Hackett Family Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":2500,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212086,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":false,"nature":"GST Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212085,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":200,"value":1000000.0,"ownership":{"direct":false,"nature":"GST Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":5000,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212084,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212083,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Non-Voting Convertible Preferred","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":200,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the \"Conversion Proposal\"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date."}],"balance_after":5000,"derivative":{"exercise_price":0,"exercise_date":"2025-03-10","underlying":"Preferred Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212082,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":625000,"ownership":{"direct":false,"nature":"Hackett Family Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":625000,"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212081,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1250000,"ownership":{"direct":false,"nature":"GST Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1212080,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":40905,"kind":"person","name":"HACKETT PATRICK T","position":1,"cik":"0001238606","reported_name":"HACKETT PATRICK T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T20:19:22.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025."}],"balance_after":1292849,"source":{"system":"sec-edgar","filing":"0001484612-25-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000034/edgardoc.xml","form_type":"4"}},{"id":1259791,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-02-19T21:30:55.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":14611,"price":0.9,"value":13149.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 28,379 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":880969,"source":{"system":"sec-edgar","filing":"0001484612-25-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000033/edgardoc.xml","form_type":"4"}},{"id":1259790,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-02-19T21:29:09.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":4204,"price":0.9,"value":3783.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 11,581 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":200764,"source":{"system":"sec-edgar","filing":"0001484612-25-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000032/edgardoc.xml","form_type":"4"}},{"id":1261854,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-02-19T21:26:21.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":6145,"price":0.9,"value":5530.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 11,934 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":175043,"source":{"system":"sec-edgar","filing":"0001484612-25-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000031/edgardoc.xml","form_type":"4"}},{"id":1259789,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":79677,"kind":"person","name":"Ahmed Nabeel","position":1,"cik":"0001870610","reported_name":"Ahmed Nabeel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:23:22.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":8659,"price":0.9,"value":7793.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 16,816 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":250210,"source":{"system":"sec-edgar","filing":"0001484612-25-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000030/edgardoc.xml","form_type":"4"}},{"id":1297496,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T23:05:34.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":18449,"price":0.8,"value":14759.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":895580,"source":{"system":"sec-edgar","filing":"0001484612-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000025/edgardoc.xml","form_type":"4"}},{"id":1297495,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T23:05:34.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":42384,"price":0.8,"value":33907.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 100,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":914029,"source":{"system":"sec-edgar","filing":"0001484612-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000025/edgardoc.xml","form_type":"4"}},{"id":1297494,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T23:05:34.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":4403,"price":0.8,"value":3522.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 11,706 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on February 2, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":956413,"source":{"system":"sec-edgar","filing":"0001484612-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000025/edgardoc.xml","form_type":"4"}},{"id":1297493,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22212,"kind":"person","name":"Trigg Leslie","position":1,"cik":"0001304125","reported_name":"Trigg Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chair and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T23:05:34.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":99419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024.   The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria.   Each PSU represents a contingent right to receive a share of common stock.   These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period."}],"balance_after":960816,"source":{"system":"sec-edgar","filing":"0001484612-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000025/edgardoc.xml","form_type":"4"}},{"id":1297492,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":304,"price":0.8,"value":243.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (2) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":204968,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1297491,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":971,"price":0.8,"value":776.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":205272,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1297490,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":21590,"price":0.8,"value":17272.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":206243,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1297489,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":356,"price":0.8,"value":284.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 824 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on March 15, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":227833,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1297488,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":1404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On July 24, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024.   The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria.   Each PSU represents a contingent right to receive a share of common stock.   These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period."}],"balance_after":228189,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1297487,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":45974,"kind":"person","name":"Nash Marc","position":1,"cik":"0001983815","reported_name":"Nash Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations and R&D"}}],"security":"Common Stock","published_at":"2025-01-22T23:04:40.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":4494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024.   The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria.   Each PSU represents a contingent right to receive a share of common stock.   These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period."}],"balance_after":226785,"source":{"system":"sec-edgar","filing":"0001484612-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000024/edgardoc.xml","form_type":"4"}},{"id":1298216,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":2679,"price":0.8,"value":2143.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":181188,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298215,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":29474,"price":0.8,"value":23579.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":183867,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298214,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":777,"price":0.8,"value":621.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,318 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":213341,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1298213,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T23:03:12.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":9090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024.   The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria.   Each PSU represents a contingent right to receive a share of common stock.   These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period."}],"balance_after":214118,"source":{"system":"sec-edgar","filing":"0001484612-25-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823381/000148461225000023/edgardoc.xml","form_type":"4"}},{"id":1297486,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":79677,"kind":"person","name":"Ahmed Nabeel","position":1,"cik":"0001870610","reported_name":"Ahmed Nabeel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-22T23:02:05.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":3907,"price":0.8,"value":3125.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":258869,"source":{"system":"sec-edgar","filing":"0001484612-25-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000022/edgardoc.xml","form_type":"4"}},{"id":1297485,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":79677,"kind":"person","name":"Ahmed Nabeel","position":1,"cik":"0001870610","reported_name":"Ahmed Nabeel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-22T23:02:05.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":29474,"price":0.8,"value":23579.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":262776,"source":{"system":"sec-edgar","filing":"0001484612-25-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000022/edgardoc.xml","form_type":"4"}},{"id":1297484,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":79677,"kind":"person","name":"Ahmed Nabeel","position":1,"cik":"0001870610","reported_name":"Ahmed Nabeel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-22T23:02:05.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":907,"price":0.8,"value":725.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,538 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":292250,"source":{"system":"sec-edgar","filing":"0001484612-25-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000022/edgardoc.xml","form_type":"4"}}],"next_cursor":"2025-01-22T23:02:05.000000Z,1297484"}